Lucid Diagnostics
$1.18
60
+$0.03+2.43% Today
Statistics
Day High
1.2
Day Low
1.12
52W High
1.8
52W Low
0.95
Volume
332,792
Avg. Volume
1,306,109
Mkt Cap
162.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18MayExpected
Expected EPS
-0.07
Actual EPS
N/A
Financials
-1,220.09%Profit Margin
Unprofitable8.69MRevenue
-106.05MNet Income
Analyst Ratings
$4.58Average Price Target
The highest estimate is 8.25.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LUCD. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Exact Sciences
EXAS
Mkt Cap12.25B
Guardant Health
GH
Mkt Cap11.72B
Fulgent Genetics
FLGT
Mkt Cap687.17M
Myriad Genetics
MYGN
Mkt Cap748.08M
QuidelOrtho
QDEL
Mkt Cap1.83B
Quest Diagnostics
DGX
Mkt Cap19.57B
Labcorp
LH
Mkt Cap21.08B
Opko Health
OPK
Mkt Cap1.04B
About
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Show more...
CEO
Dr. Lishan Aklog M.D.
Employees
72
Country
US
ISIN
US54948X1090
Listings
0 Comments
Share your thoughts
FAQ
What is Lucid Diagnostics stock price today?▼
The current price of LUCD is $1.18 USD — it has increased by +2.43% in the past 24 hours. Watch Lucid Diagnostics stock price performance more closely on the chart.
What is Lucid Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lucid Diagnostics stocks are traded under the ticker LUCD.
Is Lucid Diagnostics stock price growing?▼
LUCD stock has fallen by -1.01% compared to the previous week, the month change is a -18.19% fall, over the last year Lucid Diagnostics has showed a -17.04% decrease.
What is Lucid Diagnostics market cap?▼
Today Lucid Diagnostics has the market capitalization of 162.19M
When is the next Lucid Diagnostics earnings date?▼
Lucid Diagnostics is going to release the next earnings report on May 18, 2026.
What were Lucid Diagnostics earnings last quarter?▼
LUCD earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.09 USD resulting in a -8.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lucid Diagnostics revenue for the last year?▼
Lucid Diagnostics revenue for the last year amounts to 8.69M USD.
What is Lucid Diagnostics net income for the last year?▼
LUCD net income for the last year is -106.05M USD.
How many employees does Lucid Diagnostics have?▼
As of April 01, 2026, the company has 72 employees.
In which sector is Lucid Diagnostics located?▼
Lucid Diagnostics operates in the Health Care sector.
When did Lucid Diagnostics complete a stock split?▼
Lucid Diagnostics has not had any recent stock splits.
Where is Lucid Diagnostics headquartered?▼
Lucid Diagnostics is headquartered in New York, US.